Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...
When Sally Cox was diagnosed with light chain amyloidosis (AL) in 2019, she was shocked. Not only had she never heard of the rare disease that causes abnormal proteins (or amyloids) to build up in ...
Torie Bosch is the First Opinion editor at STAT. First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
It can be tough to share the news of a genetic health condition, but doing so empowers your relatives to take charge of their health. ATTR occurs when the protein transthyretin (TTR), which is made in ...
Researchers at Wakayama Medical University in Japan have discovered that amyloid-β deposits disrupt the formation of the ...
Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.
Just as Eisai notches wins in its campaign for lecanemab approval around the world—last month in the European Union, this week in Mexico—a dozen research and clinical leaders called on the U.S. FDA ...
The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback